The Pharma.Aero collaboration platform for life science airfreight has signed a memorandum of understanding with the Cool Chain Association, an industry association specialising in temperature-controlled logistics, to harmonise processes in the sector.
The MoU outlines the associations’ shared commitment to foster collaboration and enhance transparency between the life science and perishable supply chain.
The associations aim to compare critical control points identified in the CCA’s perishable trials with those recognised by Pharma.Aero in the pharmaceutical supply chain, using IATA’s CEIV Pharma and Fresh certifications as benchmarks to identify shared standards for improving the cold chain.
Pharma.Aero and the CCA will collaborate on projects to review and recommend new industry processes and guidelines.
CCA board chairman and head of global healthcare, Cargolux, Stavros Evangelakakis, said: “Our partnership with Pharma.Aero is born out of a shared goal to improve the quality and safety of the cool supply chain. We believe that we can achieve so much more through cross-industry collaboration than we ever could working independently in silos.”
CCA secretary general and senior quality manager, SkyCell, Nicola Caristo,added: “By promoting harmonious processes across perishables and pharma we hope to facilitate a holistic and sustainable approach to air cargo, highlighting where the industry can simplify operations with better handling, reduce waste with improved data visibility, and increase profits with more efficient processes.”
Chairman of Pharma.Aero, Trevor Caswell, commented: “We are excited about the prospect of joint industry projects that will not only drive advancements but also set new benchmarks for industry collaboration. By joining forces, we aim to leverage our collective expertise to address the evolving challenges in the life science temperature-controlled logistics.”
CCA recently launched a pharmaceutical trial in partnership with its member, Lamprecht Pharma Logistics, to identify pain points in the pharmaceutical supply chain and optimise performance.